Actively Recruiting
The Efficacy of Repetitive Transcranial Magnetic Stimulation in Patients With Chronic Subjective Tinnitus
Led by Eye & ENT Hospital of Fudan University · Updated on 2024-10-10
120
Participants Needed
1
Research Sites
84 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this study is to compare the efficacy of frequency-specific patterned repetitive transcranial magnetic stimulation (rTMS) and 1Hz rTMS for the treatment of chronic subjective tinnitus. In this single-blind randomized controlled study, patients will be randomly assigned 1:1 to receive two different types of rTMS stimulation.
CONDITIONS
Official Title
The Efficacy of Repetitive Transcranial Magnetic Stimulation in Patients With Chronic Subjective Tinnitus
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged between 18 and 80 years old
- Persistent subjective tinnitus lasting at least 3 months
- Tinnitus Handicap Inventory (THI) score of 38 or more
- Average pure tone hearing threshold of 50 dB HL or less in the worse ear (0.5, 1, 2 kHz)
- Voluntary participation with signed informed consent
- Normal mental status and cognitive function, able to cooperate with the study process
You will not qualify if you...
- Diagnosis of Meniere's disease, conductive hearing loss, or objective tinnitus
- History of epilepsy or stroke
- Diagnosis of acoustic neuroma
- Severe sensorineural hearing loss
- Presence of surgically or traumatically implanted ferromagnetic foreign bodies (e.g., pacemakers, neurostimulators, metal heart valves, aneurysm clips, cochlear implants, metal prostheses, steel plates or pins)
- Active metal foreign bodies or devices posing risk for rTMS treatment
- Use of vestibular sedatives, antipsychotics, anxiolytics, antiepileptics, or ototoxic drugs
- Recent history of alcohol or drug abuse
- Bell's palsy
- Acute ear infection within the past month
- Inability to cooperate or complete the study
- Participation in another clinical trial within the last month
- Any condition affecting compliance or safety
- Any other condition deemed inappropriate for study enrollment by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Eye & ENT Hospital of Fudan University
Shanghai, Shanghai Municipality, China, 200031
Actively Recruiting
Research Team
S
Shan Sun, PhD
CONTACT
D
Dongmei Tang, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here